Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • roliwilhelm
    Member
    • Jun 2012
    • 38

    Pulling Data from NCBI Based on Simple Criteria

    I have spent a good hour reading about NCBI BioSamples and BioProjects and using their searches to download data from environments that have metadata for "polar" and "marine" environments that were produced by 16S rRNA gene amplicon sequencing.

    I post this thread b/c I have had very little success in finding useful datasets. I expected that my search criteria are simple enough to generate a decent list of datasets, but I've had to manually pick through a very non-specific list of hits.

    Can someone comment on a good workflow to achieve what I am aiming at, or provide me with a good walk-through? Surely, this kind of basic data retrieval is common practice and should be easier than I'm finding it... right?

    Thanks in advance,
    Roli
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    I am going to hazard a guess that you can only find what is there in the first place. Sounds like sequence submitters may not be doing a good job of submitting adequate metadata.

    That said, I had recently found an R-based package to search SRA metadata and posted it in one of the threads. You can search here or I can look for that thread. Perhaps that may help.

    Here is that post: http://seqanswers.com/forums/showpos...45&postcount=9
    Last edited by GenoMax; 11-13-2015, 06:06 PM.

    Comment

    • blancha
      Senior Member
      • May 2013
      • 367

      #3
      @GenoMax's answer is certainly more useful than mine.

      I think it's a pipe dream to think that you will find all the datasets neatly organized on NCBI. You might be better off just using Google to find the articles published by the studies, and then locate the datasets.

      Inevitably, the raw datasets will be hard to locate, and incomplete. The file formats will differ from one study to the other. The library preparation protocols, and data processing steps, will vary from one study to another, and will be poorly documented.

      I myself submit data to NCBI, albeit related to human health, and I can tell you that it's a mess. Even today, there is no consensus on what data to submit, or under what format. You can imagine how it was for datasets collected a few years ago, at the dawn of next generation sequencing.

      Researchers are mainly interested in getting their paper published. Since most journals now require that the dataset be uploaded to NCBI, researchers will do so. However, providing the data to the public in a neat and organized manner is not a major preoccupation, and even for a conscientious researcher, it's not always clear under what format the data should be uploaded or with which accompanying information.
      Last edited by blancha; 11-13-2015, 07:39 PM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...